Nichol Ochsner | Vice President-Investor Relations |
Robert Finizio | Chief Executive Officer |
Daniel Cartwright | Chief Financial Officer |
Dr. Brian Bernick | Co-Founder |
Dr. Sebastian Mirkin | Chief Medical Officer |
Bill Tanner | Cantor Fitzgerald |
Ken Cacciatore | Cowen |
Dana Flanders | Goldman Sachs |
Chris Schott | JPMorgan |
Jay Olson | Oppenheimer |
Annabel Samimy | Stifel |
Good day, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD’s Second Quarter 2018 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol?